Kontakis Michael G, Tsagkozis Panagiotis
Department of Molecular Medicine and Surgery, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Department of Surgical Sciences, Orthopaedics, Uppsala University, Uppsala, Sweden.
Global Spine J. 2025 Jan;15(1):136-142. doi: 10.1177/21925682241262691. Epub 2024 Jun 13.
Retrospective Cohort Study.
Scoring systems for metastatic disease of the spine are used to select patients for surgical treatment based on survival estimation, but it is unknown whether they can be used to predict the outcome of surgery. This study aims to investigate the association between two widely used prognostic scores and the neurologic function after surgery.
Retrospective analysis of 204 patients with thoracolumbar metastases treated with decompressive surgery at Karolinska University Hospital (2001-2020). Modified Bauer and Tokuhashi scores were categorized based on surgical indication, and post-operative neurological function was assessed using the Frankel scale at two different post-surgery intervals.
Modified Bauer scores ≥2 yielded higher late follow-up Frankel scores (3.9 ± 1.1) than scores <2 (3.5 ± 1.1), = .03. Modified Tokuhashi scores ≥9 correlated with higher Frankel scores (4.5 ± .9) than scores <9 (3.5 ± 1.1), < .0001. Both scoring systems positively predicted neurological outcomes at late follow-up, with odds ratios of 1.6 ( = .03) for Bauer and 9.2 ( < .0001) for Tokuhashi. However, only Tokuhashi predicted ambulatory function at late follow-up ( < .0001), demonstrating its utility in prognosticating post-surgical mobility.
Higher modified Bauer and Tokuhashi scores were associated with better neurologic function at last follow-up, as well as greater likelihood of being able to walk again. The Tokuhashi score was found to be more accurate than the modified Bauer score in predicting the neurological outcome after surgery.
回顾性队列研究。
脊柱转移性疾病的评分系统用于根据生存估计选择手术治疗的患者,但尚不清楚它们是否可用于预测手术结果。本研究旨在探讨两种广泛使用的预后评分与术后神经功能之间的关联。
对卡罗林斯卡大学医院(2001 - 2020年)接受减压手术的204例胸腰椎转移患者进行回顾性分析。根据手术指征对改良鲍尔和德桥评分进行分类,并在两个不同的术后时间间隔使用弗兰克尔量表评估术后神经功能。
改良鲍尔评分≥2的患者在晚期随访时的弗兰克尔评分(3.9±1.1)高于评分<2的患者(3.5±1.1),P = 0.03。改良德桥评分≥9的患者弗兰克尔评分(4.5±0.9)高于评分<9的患者(3.5±1.1),P < 0.0001。两种评分系统均能在晚期随访时对神经功能结果进行正向预测,鲍尔评分的优势比为1.6(P = 0.03),德桥评分为9.2(P < 0.0001)。然而,只有德桥评分能预测晚期随访时的行走功能(P < 0.0001),表明其在预测术后活动能力方面的效用。
较高的改良鲍尔和德桥评分与末次随访时更好的神经功能以及再次行走的可能性更大相关。发现德桥评分在预测术后神经功能结果方面比改良鲍尔评分更准确。